{"id":755,"date":"2018-12-19T23:16:52","date_gmt":"2018-12-19T23:16:52","guid":{"rendered":"https:\/\/wp.uthscsa.edu\/pharmacology\/?page_id=755"},"modified":"2018-12-19T23:16:52","modified_gmt":"2018-12-19T23:16:52","slug":"flavia-carreno","status":"publish","type":"page","link":"https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/flavia-carreno\/","title":{"rendered":"Flavia Carre\u00f1o"},"content":{"rendered":"<div class=\"wpb-content-wrapper\" id=\"wpb-content-root\"><p>[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h3><span style=\"font-weight: 400\">Assistant Professor\/Research<\/span><\/h3>\n<p><span style=\"font-weight: 400\">Ph.D., Cellular and Tissue Biology<\/span><br \/>\n<span style=\"font-weight: 400\">University of S\u00e3o Paulo<\/span><br \/>\n<span style=\"font-weight: 400\">S\u00e3o Paulo, SP, Brazil<\/span><br \/>\n<span style=\"font-weight: 400\"><strong>Email:<\/strong> carrenof@uthscsa.edu<\/span><br \/>\n<span style=\"font-weight: 400\">Lab Association: Alan Frazer, Ph.D.<\/span><br \/>\n<b>Research Interests<\/b><br \/>\n&nbsp;<\/p>\n<table>\n<tbody>\n<tr>\n<td><span style=\"font-weight: 400\">\u2022 Vagal nerve stimulation<\/span><\/td>\n<td><span style=\"font-weight: 400\">\u2022 antidepressants<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">\u2022 treatment resistant depression \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><\/td>\n<td><span style=\"font-weight: 400\">\u2022 neurotrophins<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400\">\u2022 TrkB receptor<\/span><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><b>Research Activities<\/b><br \/>\n&nbsp;<br \/>\n<span style=\"font-weight: 400\">My current research focuses on alternative therapies for treatment resistant depression. Based on our recently published data showing that the sustained antidepressant-like response to ketamine is dependent on the activation of the ventral hippocampus, we propose a more translationally relevant approach by selectively targeting the hippocampus pharmacologically. In particular, we are exploiting the discrete localization of the alpha5-subunit of the GABAA receptor to modulate preferentially hippocampal activity. We have also published that such an approach produces an antidepressant-like response without the psychotomimetic effects and abuse related properties associated with the use of ketamine. Currently we are studying the mechanisms by which pharmacological augmentation of hippocampal activity produces sustained antidepressant-like effects.<\/span><br \/>\n<span style=\"font-weight: 400\"> \u00a0<\/span><br \/>\n<b> Accomplishments, Awards and Honors\u00a0<\/b><\/p>\n<ul>\n<li><span style=\"font-weight: 400\">Chair&#8217;s Award for Excellence &#8211; Research &#8211; Dec 2014<\/span><\/li>\n<li><span style=\"font-weight: 400\">William Thomas Booth Memorial Travel Award &#8211; UTHSCSA &#8211; Sept 2014<\/span><\/li>\n<\/ul>\n<p>&nbsp;<br \/>\n<b> Appointments, Boards, Committees and Memberships\u00a0<\/b><\/p>\n<ul>\n<li><span style=\"font-weight: 400\">Reviewer for Journals &#8211; Biological Psychiatry &#8211; 2018-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Poster Judge &#8211; APSA Meeting (2018), BBC Meeting (2016), Pharmacology Graduate Student Symposium (2015), Passport Retreat (2015)<\/span><\/li>\n<li><span style=\"font-weight: 400\">Chemical Safety Committee Member &#8211; UT Health San Antonio &#8211; 2017-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">START-UP Recruitment Team &#8211; St. Mary&#8217;s University &#8211; 2017<\/span><\/li>\n<li><span style=\"font-weight: 400\">Member of Center for Biomedical Neuroscience (CBN) &#8211; 2016-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Reviewer for Journals &#8211; Brain Stimulation &#8211; 2015-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Reviewer for Journals &#8211; International Journal of Neural Systems &#8211; 2015-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Reviewer for Journals &#8211; Neuropharmacology &#8211; 2015-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Grant Reviewer (ad hoc) &#8211; William &amp; Ella Owens Medical Research Foundation &#8211; 2015<\/span><\/li>\n<li><span style=\"font-weight: 400\">Brain Bowl Judge &#8211; UT Health San Antonio &#8211; 2015<\/span><\/li>\n<li><span style=\"font-weight: 400\">Reviewer for Journals &#8211; PLOS ONE &#8211; 2014-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Reviewer for Journals &#8211; Neural Regeneration Research &#8211; 2014-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Natalia High School Science Night &#8211; Registration Booth Organizer &#8211; San Antonio, TX &#8211; 2014<\/span><\/li>\n<li><span style=\"font-weight: 400\">Reviewer for Journals &#8211; Journal of Chemical Neuroanatomy &#8211; 2012-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Organizing committee for R25 students Journal Club &#8211; Department of Pharmacology, UT Health San Antonio, TX &#8211; Dec 2011-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Member of American Physiological Society (APS) &#8211; 2009-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Member of the Cardiovascular Research Institute (CRI) &#8211; 2009-Present<\/span><\/li>\n<li><span style=\"font-weight: 400\">Member of the Society for Neuroscience (SfN) &#8211; 2005-Present<\/span><\/li>\n<\/ul>\n<p>&nbsp;<br \/>\n<b> Certifications and Training\u00a0<\/b><br \/>\n<span style=\"font-weight: 400\">Genome Sequencing Facility, UT Health San Antonio &#8211; Workshop attendee: RNA-seq (4 hours) &#8211; 2015<\/span><br \/>\n<span style=\"font-weight: 400\">Office of Postdoctoral Affairs, UT Health San Antonio &#8211; Course attendee: Entering Mentorship (8 hours) &#8211; 2014<\/span><br \/>\n&nbsp;<br \/>\n<b> Grants, Funding and Research Support\u00a0<\/b><br \/>\n<span style=\"font-weight: 400\">Center for Biomedical Neuroscience (CBN) pilot project grant &#8211; (Role: PI); 01\/01\/2015-12\/31\/2017: $50,000.00. &#8211; Title: <\/span><i><span style=\"font-weight: 400\">Brain circuits underlying the antidepressant-like and abuse-related effects of ketamine<\/span><\/i><br \/>\n&nbsp;<br \/>\n<b> Lectures and Presentations<\/b><br \/>\n<i><span style=\"font-weight: 400\">Ketamine and Beyond: Novel Treatments for Major Depressive Disorder<\/span><\/i><span style=\"font-weight: 400\"> &#8211; Pharmaceutical Sciences School seminar, UFRGS &#8211; Porto Alegre RS, Brazil<\/span> <span style=\"font-weight: 400\">&#8211; 2016<\/span><br \/>\n<i><span style=\"font-weight: 400\">BDNF Receptor Signaling is Differentially Altered by Novel Antidepressants<\/span><\/i><span style=\"font-weight: 400\"> &#8211; ASPET Symposium speaker at Experimental Biology 2016, San Diego, CA<\/span><br \/>\n<i><span style=\"font-weight: 400\">Brain circuits underlying the antidepressant response to ketamine: preclinical studies<\/span><\/i><span style=\"font-weight: 400\"> &#8211; Department of Pharmacology Seminar &#8211; UT Health San Antonio &#8211; 2015<\/span><br \/>\n<i><span style=\"font-weight: 400\">Current Approaches and Technologies to Study Antidepressant Drugs in the Laboratory<\/span><\/i><span style=\"font-weight: 400\"> &#8211; UT Health San Antonio Voelcker Biosciences Teacher Academy 5th Annual Spring Conference &#8211; San Antonio, TX &#8211; 2014<\/span><br \/>\n<i><span style=\"font-weight: 400\">How we study antidepressant drugs in the laboratory<\/span><\/i><span style=\"font-weight: 400\"> &#8211; UT Health San Antonio Health Professions Fair &amp; Science Expo &#8211; 2013<\/span><br \/>\n<i><span style=\"font-weight: 400\">Life as a scientist<\/span><\/i><span style=\"font-weight: 400\"> &#8211; Special presentation to R25 students\/Round table &#8211; UT Health San Antonio &#8211; 2013<\/span><br \/>\n<span style=\"font-weight: 400\"> \u00a0\u00a0<\/span><br \/>\n<b>Selected Publications<\/b><\/p>\n<ul>\n<li style=\"font-weight: 400\"><b>Carreno FR<\/b><span style=\"font-weight: 400\">, Frazer A. (2017)<\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28585221\"> <span style=\"font-weight: 400\">Vagal Nerve Stimulation for Treatment-Resistant Depression<\/span><\/a> <i><span style=\"font-weight: 400\">Neurotherapeutics<\/span><\/i><span style=\"font-weight: 400\"> Jul;14(3):716-727.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Carreno FR<\/b><span style=\"font-weight: 400\">, Collins GT, Frazer A, Lodge JD. (2017)_<\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28339593\"><span style=\"font-weight: 400\">Selective pharmacological augmentation of hippocampal activity produces a sustained antidepressant-like response without abuse-related or psychotomimetic effects<\/span><\/a> <i><span style=\"font-weight: 400\">Int J Neuropsychopharmacol.<\/span><\/i><span style=\"font-weight: 400\"> Jun 1;20(6):504-509.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Carreno FR<\/b><span style=\"font-weight: 400\">, Donegan JJ, Boley AM, Shah A, DeGuzman M, Frazer A, Lodge DJ. (2016)<\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26619811\"> <span style=\"font-weight: 400\">Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine<\/span><\/a> <i><span style=\"font-weight: 400\">Mol Psychiatry.<\/span><\/i><span style=\"font-weight: 400\"> Sep;21(9):1298-308.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Carreno FR<\/b><span style=\"font-weight: 400\">, Frazer A. (2016)<\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26796874\"> <span style=\"font-weight: 400\">The allure of transcutaneous vagus nerve stimulation as a novel therapeutic modality<\/span><\/a> <i><span style=\"font-weight: 400\">Biol Psychiatry.<\/span><\/i><span style=\"font-weight: 400\"> Feb 15;79(4):260-1.<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Shah AP, <\/span><b>Carreno FR<\/b><span style=\"font-weight: 400\">, Wu H, Chung YA, Frazer A. (2016)<\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26899129\"> <span style=\"font-weight: 400\">Role of TrkB in the anxiolytic-like and antidepressant-like effects of vagal nerve stimulation: comparison with desipramine<\/span><\/a> <i><span style=\"font-weight: 400\">Neuroscience<\/span><\/i><span style=\"font-weight: 400\"> May 13; 322:273-86.<\/span><\/li>\n<li style=\"font-weight: 400\"><\/li>\n<li style=\"font-weight: 400\"><b>Selected Abstracts<\/b><\/li>\n<li style=\"font-weight: 400\"><b>Carreno FR<\/b><span style=\"font-weight: 400\">, Arroyo, L.D., Lodge DJ., Frazer A. <\/span><i><span style=\"font-weight: 400\">Novel mechanisms contributing to the antidepressant-like effect of pharmacological hippocampal activation<\/span><\/i><span style=\"font-weight: 400\"> Program No. 610.27. Neuroscience Meeting Planner &#8211; Washington, DC: Society for Neuroscience, 2017. Online.<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Carreno FR<\/b><span style=\"font-weight: 400\">, Frazer A, Lodge DJ. <\/span><i><span style=\"font-weight: 400\">Optogenetic inactivation of the ventral hippocampus-medial prefrontal cortex pathway reverses the antidepressant-like effects of ketamine<\/span><\/i><span style=\"font-weight: 400\"> Program No. 410.13. Neuroscience Meeting Planner &#8211; Chicago, IL: Society for Neuroscience, 2015. Online<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Carreno, FR.<\/b><span style=\"font-weight: 400\">, Shah, A., Frazer, A. and Lodge, DJ. <\/span><i><span style=\"font-weight: 400\">Involvement of the ventral hippocampus in the antidepressant-like effect of ketamine in rats<\/span><\/i><span style=\"font-weight: 400\"> ACNP 53rd meeting, Phoenix, AZ., USA, 2014<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Carreno, FR.<\/b><span style=\"font-weight: 400\">, DeGuzman, M., Shah, A., Lodge, DJ. and Frazer, A. <\/span><i><span style=\"font-weight: 400\">Involvement of the ventral hippocampus in the antidepressant-like effect of ketamine: Behavioral and optogenetic studies<\/span><\/i><span style=\"font-weight: 400\"> Program No. 425.10. Neuroscience Meeting Planner &#8211; Washington, DC: Society for Neuroscience, 2014 &#8211; Online<\/span><\/li>\n<li style=\"font-weight: 400\"><b>Carreno, FR.<\/b><span style=\"font-weight: 400\">, Frazer, A. and Lodge D. <\/span><i><span style=\"font-weight: 400\">Involvement of the ventral hippocampus ascending pathway to the medial prefrontal cortex in the antidepressant-like effect of ketamine in rats<\/span><\/i><span style=\"font-weight: 400\"> 21st Annual Department of Pharmacology Graduate Student Symposium, San Antonio, TX., USA, Oct. 2014<\/span><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/3&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text] Assistant Professor\/Research Ph.D., Cellular and Tissue Biology University of S\u00e3o Paulo S\u00e3o Paulo, SP, Brazil Email: carrenof@uthscsa.edu Lab Association: Alan Frazer, Ph.D. Research Interests &nbsp; \u2022 Vagal nerve stimulation \u2022 antidepressants \u2022 treatment resistant depression \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 neurotrophins \u2022 TrkB receptor Research Activities &nbsp; My current research focuses on alternative therapies for treatment [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":747,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/child-page.php","meta":{"footnotes":""},"class_list":["post-755","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Flavia Carre\u00f1o - Department of Pharmacology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/flavia-carreno\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Flavia Carre\u00f1o - Department of Pharmacology\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text] Assistant Professor\/Research Ph.D., Cellular and Tissue Biology University of S\u00e3o Paulo S\u00e3o Paulo, SP, Brazil Email: carrenof@uthscsa.edu Lab Association: Alan Frazer, Ph.D. Research Interests &nbsp; \u2022 Vagal nerve stimulation \u2022 antidepressants \u2022 treatment resistant depression \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 neurotrophins \u2022 TrkB receptor Research Activities &nbsp; My current research focuses on alternative therapies for treatment [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/flavia-carreno\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Pharmacology\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/research-faculty\\\/flavia-carreno\\\/\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/research-faculty\\\/flavia-carreno\\\/\",\"name\":\"Flavia Carre\u00f1o - Department of Pharmacology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/#website\"},\"datePublished\":\"2018-12-19T23:16:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/research-faculty\\\/flavia-carreno\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/research-faculty\\\/flavia-carreno\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/research-faculty\\\/flavia-carreno\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Research Faculty\",\"item\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/research-faculty\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Flavia Carre\u00f1o\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/#website\",\"url\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/\",\"name\":\"Department of Pharmacology\",\"description\":\"Department of Pharmacology\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lsom.uthscsa.edu\\\/pharmacology\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Flavia Carre\u00f1o - Department of Pharmacology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/flavia-carreno\/","og_locale":"en_US","og_type":"article","og_title":"Flavia Carre\u00f1o - Department of Pharmacology","og_description":"[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text] Assistant Professor\/Research Ph.D., Cellular and Tissue Biology University of S\u00e3o Paulo S\u00e3o Paulo, SP, Brazil Email: carrenof@uthscsa.edu Lab Association: Alan Frazer, Ph.D. Research Interests &nbsp; \u2022 Vagal nerve stimulation \u2022 antidepressants \u2022 treatment resistant depression \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 neurotrophins \u2022 TrkB receptor Research Activities &nbsp; My current research focuses on alternative therapies for treatment [&hellip;]","og_url":"https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/flavia-carreno\/","og_site_name":"Department of Pharmacology","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/flavia-carreno\/","url":"https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/flavia-carreno\/","name":"Flavia Carre\u00f1o - Department of Pharmacology","isPartOf":{"@id":"https:\/\/lsom.uthscsa.edu\/pharmacology\/#website"},"datePublished":"2018-12-19T23:16:52+00:00","breadcrumb":{"@id":"https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/flavia-carreno\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/flavia-carreno\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/flavia-carreno\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lsom.uthscsa.edu\/pharmacology\/"},{"@type":"ListItem","position":2,"name":"Research Faculty","item":"https:\/\/lsom.uthscsa.edu\/pharmacology\/research-faculty\/"},{"@type":"ListItem","position":3,"name":"Flavia Carre\u00f1o"}]},{"@type":"WebSite","@id":"https:\/\/lsom.uthscsa.edu\/pharmacology\/#website","url":"https:\/\/lsom.uthscsa.edu\/pharmacology\/","name":"Department of Pharmacology","description":"Department of Pharmacology","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lsom.uthscsa.edu\/pharmacology\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/lsom.uthscsa.edu\/pharmacology\/wp-json\/wp\/v2\/pages\/755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lsom.uthscsa.edu\/pharmacology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lsom.uthscsa.edu\/pharmacology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/pharmacology\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/pharmacology\/wp-json\/wp\/v2\/comments?post=755"}],"version-history":[{"count":0,"href":"https:\/\/lsom.uthscsa.edu\/pharmacology\/wp-json\/wp\/v2\/pages\/755\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/lsom.uthscsa.edu\/pharmacology\/wp-json\/wp\/v2\/pages\/747"}],"wp:attachment":[{"href":"https:\/\/lsom.uthscsa.edu\/pharmacology\/wp-json\/wp\/v2\/media?parent=755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}